Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Solvonis Therap (SVNS) Share Price

Price 0.25p on 20-05-2026 at 16:30:01
Change 0.005p 2.04%
Buy 0.26p
Sell 0.24p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 836,159.00 at 0.246p
Day's Volume: 20,518,494
Last Close: 0.25p
Open: 0.242p
ISIN: GB00BMD1Z199
Day's Range 0.242p - 0.25p
52wk Range: 0.127p - 0.395p
Market Capitalisation: £17.02m
VWAP: 0.245413p
Shares in Issue: 6.81b

Sector: Medicine and Biotech

Solvonis Therap (SVNS) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 836,159 0.246p Ordinary
 11:43:29 - 20-May-26
Unknown* 750,000 0.25p Ordinary
 10:24:18 - 20-May-26
Buy* 1,200,480 0.2499p Ordinary
 10:20:56 - 20-May-26
Buy* 100,000 0.25p Ordinary
 10:20:56 - 20-May-26
Buy* 2,829,426 0.2474p Ordinary
 10:17:30 - 20-May-26
Sell* 828,634 0.2422p Ordinary
 10:10:23 - 20-May-26
Buy* 2,000,000 0.2465p Ordinary
 09:48:31 - 20-May-26
Sell* 991,475 0.242p Ordinary
 09:34:15 - 20-May-26
Buy* 18,664 0.25p Ordinary
 09:34:06 - 20-May-26
Buy* 3,252,032 0.246p Ordinary
 09:17:19 - 20-May-26
See more Solvonis Therap trades

Solvonis Therap (SVNS) Share Price History

Time period:
to
Date Open High Low Close Volume
19th May 2026 (Tue) 0.225 0.245 0.225 0.245 68,712,373
18th May 2026 (Mon) 0.225 0.235 0.22 0.225 36,035,529
15th May 2026 (Fri) 0.221 0.245 0.22 0.245 21,910,394
14th May 2026 (Thu) 0.22 0.24 0.22 0.225 18,034,270
13th May 2026 (Wed) 0.24 0.225 0.219 0.219 45,029,984
12th May 2026 (Tue) 0.24 0.24 0.235 0.24 5,887,801
11th May 2026 (Mon) 0.24 0.24 0.24 0.24 16,713,604
8th May 2026 (Fri) 0.245 0.24 0.23 0.24 32,967,323
7th May 2026 (Thu) 0.24 0.26 0.23 0.23 13,204,900
6th May 2026 (Wed) 0.235 0.255 0.23 0.255 30,834,825
5th May 2026 (Tue) 0.24 0.24 0.23 0.235 23,579,524
4th May 2026 (Mon) 0.25 0.25 0.25 0.25 0
1st May 2026 (Fri) 0.235 0.25 0.23 0.25 18,808,517
30th Apr 2026 (Thu) 0.24 0.25 0.24 0.24 39,100,467
29th Apr 2026 (Wed) 0.275 0.275 0.24 0.24 56,188,696
28th Apr 2026 (Tue) 0.29 0.269 0.269 0.269 22,055,109
27th Apr 2026 (Mon) 0.285 0.295 0.27 0.29 30,133,774
24th Apr 2026 (Fri) 0.285 0.285 0.275 0.28 65,091,950
23rd Apr 2026 (Thu) 0.305 0.32 0.285 0.285 34,597,689
22nd Apr 2026 (Wed) 0.305 0.32 0.305 0.305 75,660,667
21st Apr 2026 (Tue) 0.30 0.31 0.295 0.31 18,970,941
20th Apr 2026 (Mon) 0.28 0.32 0.30 0.306 104,543,651
See more Solvonis Therap price history

Solvonis Therap (SVNS) Regulatory News

Date Source Headline
5th May 2026 7:00 am RNS-R CSO Speaks at National Research Meeting
29th Apr 2026 7:00 am RNS Final Results
22nd Apr 2026 7:00 am RNS-R Appointment of Water Tower Research
20th Apr 2026 8:32 am RNS-R US CNS Executive Order
8th Apr 2026 7:00 am RNS Granted U.S. Patent from PTSD Discovery Programme
31st Mar 2026 7:00 am RNS Granted U.S. Patent from PTSD Discovery Programme
10th Mar 2026 7:00 am RNS SVN-114 selected for PTSD discovery programme
28th Jan 2026 7:00 am RNS Expansion of SVN-015 into depression
7th Jan 2026 7:00 am RNS US Patent allowance for PTSD discovery programme
22nd Dec 2025 7:00 am RNS Research and Development Update - Q4 2025
See more Solvonis Therap regulatory news

Solvonis Therap (SVNS) Share News

WINNERS & LOSERS: Advanced Medical suitor walks away; Capita climbs

18th May 2026 09:52

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More

EARNINGS: Sanderson swings to profit; Keystone Law revenue climbs

29th Apr 2026 12:07

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Catenai renews contract; Angus sees production uplift

20th Apr 2026 19:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

WINNERS & LOSERS: Kosmos Energy climbs; Feedback hit by NHS delay

20th Apr 2026 11:20

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More

IN BRIEF: Solvonis Therapeutics hails US patent from PTSD programme

8th Apr 2026 14:31

Solvonis Therapeutics PLC - London-based biopharmaceutical company, focused on central nervous system disorders - Celebrates second US patent by United States Patent & Trademark Office, covering a further monoamine modulator compound series arising from its proprietary post-traumatic stress disorder discovery programme. The patent, U.S. Patent No. 12,595,269, was issued on Tuesday. On March 31, the company had announced the first such patent, U.S. Patent No. 12,590,077. Read More

See more Solvonis Therap news
FTSE 100 Latest
Value10,432.34
Change101.79

Login to your account

Forgot Password?

Not Registered